Two Nebraska researchers have launched a startup company aimed at bringing to market an innovative method for delivering therapeutics, gene editing tools, plasmids and more to targeted locations in ...
Professor Schekman (second from the right) and Superintendent Cho (rightmost) attended the forum to discuss the potential of exosomal technology in clinical applications. Dr. Chang-Hai Tsai, Chairman ...